✦ LIBER ✦

A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children

✍ Scribed by Amalia Guadalupe Becerra Aquino; Maricruz Gutiérrez Brito; Carlos E. Aranza Doniz; Juan Francisco Galán Herrera; Mercedes Macias; Betzana Zambrano; Eric Plennevaux; Eduardo Santos-Lima

Book ID: 118503200
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 334 KB
Volume: 30
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.07.040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of a primary s

Immunogenicity and safety of a primary series of a new fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine (Hexaxim™) co-administered with Prevenar™ and Rotarix™ in healthy children in Latin America

✍ P. Lopez; A. Arguedas Mohs; M.-C. Miranda; B. Zambrano; E. Santos Lima 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Antibody persistence at 18–20 month

Antibody persistence at 18–20 months of age and safety and immunogenicity of a booster dose of a combined DTaP–IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China

✍ Rong Cheng Li; Feng Xiang Li; Yan Ping Li; Qi Ming Hou; Chang Gui Li; Ya Nan Li; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 563 KB

Combined immunogenicity data for a new D

Combined immunogenicity data for a new DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim™) following primary series administration at 2, 4, 6 months of age in Latin America

✍ Santos-Lima, Eduardo; B’Chir, Siham; Lane, Andrew 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 158 KB